Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 22 peer-reviewed journal articles Updated
Cardiology · Obstructive Hypertrophic Cardiomyopathy

Septal Myectomy vs. Alcohol Ablation: Which is Best?

At a Glance

Septal myectomy is an open-heart surgery offering immediate, long-lasting relief and is the gold standard for HCM. Alcohol septal ablation is a minimally invasive alternative with a faster recovery, but it carries a higher risk of needing a permanent pacemaker.

In this answer

3 sections

01

Surgical Septal Myectomy (The Gold Standard)

02

Alcohol Septal Ablation (The Minimally Invasive Option)

03

How Do Doctors Decide?

When medications are no longer enough to manage symptoms of obstructive hypertrophic cardiomyopathy (HCM), doctors often recommend a procedure to reduce the thickened heart muscle—a process called septal reduction therapy. The two primary options are septal myectomy, an open-heart surgery to remove a portion of the thickened muscle, and alcohol septal ablation, a minimally invasive catheter procedure that shrinks the muscle using medical-grade alcohol [1][2]. Both are highly effective at relieving symptoms, but surgical myectomy is generally considered the “gold standard” because it provides more thorough, long-lasting relief and has a lower risk of certain complications, like needing a pacemaker [3][4][5]. The best choice for you will depend on your heart’s specific anatomy, your age and overall health, and your personal preferences [6][7].

Surgical Septal Myectomy (The Gold Standard)

Septal myectomy is an open-heart surgery where a surgeon accesses your heart and carefully removes the extra, thickened muscle from the septum (the wall separating the heart’s chambers) [8].

  • How it works: You are placed under general anesthesia, and the surgeon physically removes the obstructing tissue to widen the path for blood flow [3].
  • Advantages: Because the muscle is physically removed, relief from blood flow blockage is usually immediate [4]. It also allows surgeons to fix other structural issues at the same time, such as abnormalities in the mitral valve or papillary muscles, which are common in HCM [9][8]. Myectomy has a very low rate of needing repeat procedures later [10][4]. It is also strongly preferred for younger patients, as it provides durable, lifelong relief without creating a permanent ablation scar [11].
  • Disadvantages: It is a major open-heart surgery. This requires a longer hospital stay (usually 5 to 7 days) and a longer recovery period at home. It typically takes 6 to 8 weeks before you can safely return to work, driving, and normal physical activities.

Alcohol Septal Ablation (The Minimally Invasive Option)

Alcohol septal ablation (ASA) is a catheter-based procedure performed in a cardiac catheterization lab [12].

  • How it works: A thin tube (catheter) is threaded through a blood vessel in your groin or wrist up to your heart. The doctor locates the small artery supplying blood to the thickened part of your septum and injects a small amount of pure alcohol. This intentionally causes a small, controlled heart attack (myocardial infarction) that kills the extra muscle cells [2][12]. Over the next several weeks to months, this tissue turns into a thin scar, slowly shrinking the blockage.
  • Advantages: It does not require open-heart surgery, meaning less physical trauma, a shorter hospital stay (typically 2 to 3 days), and a faster recovery. Most patients can return to normal activities in about 1 to 2 weeks [12][1].
  • Disadvantages: Because the muscle shrinks slowly over time, it can take weeks or months to feel the full relief of symptoms. It is also not suitable for everyone, as it requires a specific blood vessel layout to deliver the alcohol safely [9]. The risk of needing a permanent pacemaker afterward is significantly higher than with surgery [5][10]. It also has a higher chance of requiring a repeat procedure if the muscle doesn’t shrink enough [4][13].

How Do Doctors Decide?

The choice between myectomy and ablation is rarely one-size-fits-all. A multidisciplinary heart team will evaluate several key factors [6]:

  • Your Anatomy: This is the most crucial factor. If you have complex blockages (like a very long segment of thickened muscle) or issues with your mitral valve, surgery is almost always preferred because these cannot be fixed with a catheter [9][14]. Conversely, if you don’t have a specific “septal branch” artery supplying the thickened area, ablation isn’t physically possible [15].
  • Age and Surgical Risk: Historically, ablation was reserved for older patients or those too fragile for open-heart surgery [1][16]. However, modern surgical techniques have made myectomy safe even for healthy older adults [17][16]. Today, severe co-existing conditions matter more than age alone when recommending ablation [18][19]. For younger patients, surgery is often favored to maximize long-term outcomes and avoid a permanent pacemaker [20][11].
  • Pacemaker Risk: The risk of complete heart block—an electrical issue requiring a permanent pacemaker—is an important consideration. Patients undergoing alcohol ablation have more than twice the risk of needing a permanent pacemaker compared to those having surgery [10][5]. Studies show the risk of complete heart block with ablation is roughly 6.5% to 11%, whereas the risk with surgery is generally much lower [21].
  • Expertise Matters: Both procedures require significant skill. Guidelines strongly recommend that whichever procedure you choose, it should be performed at a high-volume center that specializes in HCM [22][1]. When consulting with a center, it is entirely appropriate to ask how many of these specific procedures their team performs annually, as experience directly impacts your safety and success.

Procedure Comparison at a Glance

Feature Surgical Septal Myectomy Alcohol Septal Ablation
Approach Open-heart surgery Minimally invasive catheter
Hospital Stay 5 to 7 days 2 to 3 days
At-Home Recovery 6 to 8 weeks 1 to 2 weeks
Symptom Relief Usually immediate Gradual (weeks to months)
Pacemaker Risk Lower Higher (approx. 6.5% to 11%)
Repeat Procedure Risk Very Low Higher

Common questions in this guide

What is the difference between septal myectomy and alcohol septal ablation?
Septal myectomy is an open-heart surgery that physically removes thickened heart muscle to immediately improve blood flow. Alcohol septal ablation is a minimally invasive catheter procedure that uses medical alcohol to shrink the extra muscle over several weeks or months.
Which HCM procedure has a faster recovery time?
Alcohol septal ablation has a much faster recovery time. Patients usually leave the hospital in 2 to 3 days and return to normal activities in 1 to 2 weeks. In contrast, surgical myectomy requires a 5 to 7 day hospital stay and 6 to 8 weeks of at-home recovery.
Does alcohol septal ablation have a higher risk of needing a pacemaker?
Yes, patients who undergo alcohol septal ablation have more than twice the risk of needing a permanent pacemaker compared to those who have surgery. The risk of complete heart block with ablation is roughly 6.5% to 11%.
Can any HCM patient choose alcohol septal ablation?
No, alcohol septal ablation requires a specific blood vessel layout to deliver the alcohol safely. If you do not have a specific septal branch artery supplying the thickened area, or if you also have mitral valve issues, open-heart surgery is typically required.
Is surgical myectomy safe for older adults?
Yes, modern surgical techniques have made septal myectomy safe for healthy older adults. Today, severe co-existing health conditions matter more than age alone when deciding if you are a candidate for surgery or ablation.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many septal myectomies and alcohol septal ablations does this center perform annually, and what are your personal complication rates?
  2. 2.Looking at my cardiac MRI and echocardiogram, is my anatomy suitable for both options, or does it strongly favor one over the other?
  3. 3.Do I have any issues with my mitral valve or papillary muscles that would require repair during a surgical myectomy?
  4. 4.Given my age and heart's electrical system, what is my specific, personal risk of needing a permanent pacemaker with either procedure?
  5. 5.If I choose alcohol septal ablation and it does not relieve my symptoms, would I be a candidate for a surgical myectomy in the future?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

Can Non-Obstructive HCM Become Obstructive Over Time?Can You Exercise with Hypertrophic Cardiomyopathy?Is Pregnancy Safe With Hypertrophic Cardiomyopathy?Does HCM Symptom Severity Vary Among Family Members?How to Manage Anxiety After an ICD Implant for HCM?Is Hypertrophic Cardiomyopathy Hereditary? | Inciteful MedHow Do Cardiac Myosin Inhibitors Treat HCM Symptoms?What Are the Emergency Red Flag Symptoms of HCM?What Are the Risk Factors for Needing an ICD in HCM?What is an LVOT Gradient in Hypertrophic Cardiomyopathy?What is Late Gadolinium Enhancement (LGE) on an HCM MRI?What Is Latent Obstruction in HCM & How Is It Tested?What is Mitral Valve SAM in Hypertrophic Cardiomyopathy?What is the Difference Between Athlete's Heart and HCM?What Is the Life Expectancy for Someone With HCM?Why is a Normal Ejection Fraction a Warning in HCM?Why is Hydration Important for HCM? | Inciteful MedWhy is HCM Misdiagnosed as Asthma or Panic Attacks?Why Choose an HCM Center of Excellence?

References

References (22)
  1. 1

    Treatment Strategies for Hypertrophic Cardiomyopathy: Alcohol Septal Ablation and Procedural Step-by-Step Technique.

    Bali AD, Malik A, Naidu SS

    The American journal of cardiology 2024; (212S()):S42-S52 doi:10.1016/j.amjcard.2023.10.064.

    PMID: 38368036
  2. 2

    Choice of Septal Reduction Therapies and Alcohol Septal Ablation.

    Fifer MA

    Cardiology clinics 2019; (37(1)):83-93 doi:10.1016/j.ccl.2018.08.009.

    PMID: 30447719
  3. 3

    The consolidation of surgery for hypertrophic obstructive cardiomyopathy in Asia and the Pacific Rim.

    Quintana E, Mestres CA

    Asian cardiovascular & thoracic annals 2022; (30(1)):5-7 doi:10.1177/02184923211057323.

    PMID: 34747236
  4. 4

    Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy: A propensity score-matched cohort.

    Nguyen A, Schaff HV, Hang D, et al.

    The Journal of thoracic and cardiovascular surgery 2019; (157(1)):306-315.e3 doi:10.1016/j.jtcvs.2018.08.062.

    PMID: 30279000
  5. 5

    Septal Myectomy or Alcohol Ablation for Hypertrophic Cardiomyopathy: A Nationwide Inpatient Sample (NIS) Database Analysis.

    Ullah W, Warner E, Khandait H, et al.

    Cardiovascular revascularization medicine : including molecular interventions 2023; (50()):54-58 doi:10.1016/j.carrev.2023.01.013.

    PMID: 36737383
  6. 6

    Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary Perspective.

    Gragnano F, Pelliccia F, Guarnaccia N, et al.

    Journal of clinical medicine 2023; (12(8)) doi:10.3390/jcm12082810.

    PMID: 37109147
  7. 7

    Invasive Management of Hypertrophic Cardiomyopathy With Clinically Important Obstruction: Surgical Myectomy Is Superior, but Only When Accessible.

    Fortier JH, Thapa Y, Crean AM, et al.

    The Canadian journal of cardiology 2024; (40(5)):843-850 doi:10.1016/j.cjca.2023.11.040.

    PMID: 38052300
  8. 8

    Interventions in Hypertrophic Obstructive Cardiomyopathy.

    Ding WY, Meah MN, Stables R, Cooper RM

    The Canadian journal of cardiology 2024; (40(5)):833-842 doi:10.1016/j.cjca.2023.12.001.

    PMID: 38070769
  9. 9

    Septal Myectomy for Isolated Midventricular Obstruction After Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy.

    Karadzha A, Schaff HV

    Annals of thoracic surgery short reports 2025; (3(2)):539-542 doi:10.1016/j.atssr.2024.10.007.

    PMID: 40525159
  10. 10

    A Systematic Review and Meta-Analysis of Long-Term Outcomes After Septal Reduction Therapy in Patients With Hypertrophic Cardiomyopathy.

    Liebregts M, Vriesendorp PA, Mahmoodi BK, et al.

    JACC. Heart failure 2015; (3(11)):896-905.

    PMID: 26454847
  11. 11

    Survival Following Alcohol Septal Ablation or Septal Myectomy for Patients With Obstructive Hypertrophic Cardiomyopathy.

    Cui H, Schaff HV, Wang S, et al.

    Journal of the American College of Cardiology 2022; (79(17)):1647-1655 doi:10.1016/j.jacc.2022.02.032.

    PMID: 35483751
  12. 12

    Alcohol septal ablation in hypertrophic cardiomyopathy.

    Mateo JJS, Gimeno JR

    Global cardiology science & practice 2018; (2018(3)):30 doi:10.21542/gcsp.2018.30.

    PMID: 30393642
  13. 13

    Alcohol septal ablation versus surgical septal myectomy of obstructive hypertrophic cardiomyopathy: systematic review and meta-analysis.

    Yokoyama Y, Shimoda T, Shimada YJ, et al.

    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2023; (63(3)) doi:10.1093/ejcts/ezad043.

    PMID: 36782361
  14. 14

    Alcohol septal ablation: in which patients and why?

    Spirito P, Rossi J, Maron BJ

    Annals of cardiothoracic surgery 2017; (6(4)):369-375 doi:10.21037/acs.2017.05.09.

    PMID: 28944178
  15. 15

    Hypertrophic obstructive cardiomyopathy-a cardiologist's perspective.

    Bahl A

    Indian journal of thoracic and cardiovascular surgery 2026; (42(2)):291-300 doi:10.1007/s12055-025-02105-4.

    PMID: 41613492
  16. 16

    Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy in the Elderly.

    Wong LY, Alver N, Dewey EN, et al.

    The Annals of thoracic surgery 2022; (113(5)):1477-1481 doi:10.1016/j.athoracsur.2021.05.058.

    PMID: 34139186
  17. 17

    Outcomes of Septal Myectomy beyond 65 Years, with and without Concomitant Procedures.

    Pruna-Guillen R, Pereda D, Castellà M, et al.

    Journal of clinical medicine 2021; (10(16)) doi:10.3390/jcm10163499.

    PMID: 34441795
  18. 18

    Alcohol septal ablation in drug-refractory hypertrophic obstructive cardiomyopathy patient with multiple comorbidities.

    Sato R, Sakamoto A, Suwa K, et al.

    Journal of cardiology cases 2025; (31(1)):5-8 doi:10.1016/j.jccase.2024.09.003.

    PMID: 39839736
  19. 19

    Guideline-Based Referral for Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy Is Associated With Excellent Clinical Outcomes.

    Kimmelstiel C, Zisa DC, Kuttab JS, et al.

    Circulation. Cardiovascular interventions 2019; (12(7)):e007673 doi:10.1161/CIRCINTERVENTIONS.118.007673.

    PMID: 31296080
  20. 20

    Hypertrophic Obstructive Cardiomyopathy: Comparison of Outcomes After Myectomy or Alcohol Ablation.

    Meng X, Wang WY, Gao J, et al.

    Frontiers in cardiovascular medicine 2022; (9()):755376 doi:10.3389/fcvm.2022.755376.

    PMID: 35360040
  21. 21

    Predicting complete heart block after alcohol septal ablation for hypertrophic cardiomyopathy using a risk stratification model and clinical tool.

    Karimianpour A, Heizer J, Leaphart D, et al.

    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2021; (98(2)):393-400 doi:10.1002/ccd.29478.

    PMID: 33491861
  22. 22

    Regional Disparities in the Use of Septal Reduction Therapy and Associated Outcomes in the United States (from a Real-World Database).

    Ashraf M, Jahangir A, Jan MF, Tajik AJ

    The American journal of cardiology 2023; (191()):51-58 doi:10.1016/j.amjcard.2022.12.008.

    PMID: 36640600

This page compares septal reduction therapies for educational purposes only. Always consult a specialized cardiologist or cardiac surgeon to determine which procedure is best for your specific heart anatomy and health profile.

Get notified when new evidence is published on Hypertrophic Cardiomyopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.